C-MIP inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the C-Maf-inducing protein (C-MIP). C-MIP is a key intracellular protein involved in various cellular signaling pathways, particularly those related to actin cytoskeleton regulation and cellular differentiation. This protein plays a significant role in the modulation of T-cell receptor signaling, impacting various downstream processes that influence cellular behavior, including migration, adhesion, and immune response regulation. By inhibiting C-MIP, these compounds can alter the normal functioning of these pathways, leading to changes in how cells respond to various internal and external signals.
The precise mechanism of C-MIP inhibitors involves binding to the C-MIP protein or its associated complexes, thereby disrupting its role in protein-protein interactions. These inhibitors typically exhibit specificity toward C-MIP, making them valuable tools for studying the molecular pathways influenced by this protein in both normal and abnormal cellular processes. Researchers use C-MIP inhibitors to gain deeper insights into actin dynamics, cell signaling cascades, and other related functions, enabling them to better understand how C-MIP contributes to cellular structure and activity. This class of inhibitors provides a useful chemical approach to dissecting the molecular intricacies of cell behavior and how C-MIP influences these mechanisms on a cellular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
JAK Inhibitor I | 457081-03-7 | sc-204021 sc-204021A | 500 µg 1 mg | $156.00 $339.00 | 59 | |
C-MIP is involved in JAK-STAT signaling. By inhibiting JAK3, this compound can indirectly affect C-MIP activity. | ||||||
Stat3 inhibitor V, stattic | 19983-44-9 | sc-202818 sc-202818A sc-202818B sc-202818C sc-202818D sc-202818E sc-202818F | 25 mg 100 mg 250 mg 500 mg 1 g 2.5 g 5 g | $130.00 $196.00 $274.00 $512.00 $731.00 $1408.00 $2091.00 | 114 | |
Inhibits STAT3 activation, potentially affecting C-MIP function if STAT3 signaling is involved. | ||||||
AG-490 | 133550-30-8 | sc-202046C sc-202046A sc-202046B sc-202046 | 5 mg 50 mg 25 mg 10 mg | $84.00 $329.00 $223.00 $87.00 | 35 | |
Inhibits JAK2, another protein involved in the JAK-STAT pathway, indirectly influencing C-MIP's function. | ||||||
Stat3 Inhibitor III, WP1066 | 857064-38-1 | sc-203282 | 10 mg | $132.00 | 72 | |
Targets STAT3 and JAK2, potentially impacting pathways where C-MIP plays a role. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Another JAK inhibitor that can interfere with JAK-STAT signaling and thereby C-MIP's role in this pathway. | ||||||
Nifuroxazide | 965-52-6 | sc-204128 sc-204128A | 500 mg 5 g | $203.00 $520.00 | 5 | |
Inhibits STAT activation and can influence the functions of C-MIP if STAT signaling is implicated. | ||||||
Baricitinib | 1187594-09-7 | sc-364730 sc-364730A | 5 mg 25 mg | $200.00 $664.00 | ||
Yet another JAK inhibitor, targeting JAK1 and JAK2, which can affect C-MIP's associated processes. | ||||||
Cryptotanshinone | 35825-57-1 | sc-280649 | 10 mg | $119.00 | 1 | |
Known as a STAT3 inhibitor, it might impact C-MIP's function if STAT3 signaling is crucial. | ||||||
Stat3 Inhibitor VI, S3I-201 | 501919-59-1 | sc-204304 | 10 mg | $151.00 | 104 | |
A specific STAT3 inhibitor; can influence C-MIP's role if it's associated with STAT3 signaling. | ||||||
Janex-1 | 202475-60-3 | sc-205354 sc-205354A | 1 mg 5 mg | $36.00 $153.00 | 1 | |
Targets JAK3, another component of the JAK-STAT pathway. May indirectly affect C-MIP's function in this pathway. | ||||||